The race for antibodies

Apr 13, 2020
Researchers hope that antibodies of those who have recovered from COVID-19 can be used in a treatment.
Researchers are looking into new treatments and preventions for COVID-19. Above, a researcher developing a test for the disease in February in New Jersey.
Kena Betancur/Getty Images

Bringing down the cost of bionic arms

Jan 9, 2020
Prosthetic limbs are essential for many people. But they are also expensive. One possible solution? Technology.
A 3D-printed bionic arm, created by Limbitless. The company hopes to bring down the cost of robotic prosthetics.
Sabri Ben-Achour/Marketplace

The cost of preventing the spread of HIV? Upwards of $1,600 a month

by
Feb 5, 2019
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
AIDS Healthcare Foundation (AHF) and AIDS patients march to protest budget cuts to AIDS services proposed by California Governor Arnold Schwarzenegger on June 5, 2009 in Hollywood, California. 
David McNew/Getty Images

Bayer sheds some brands to focus on pharma and fight pesticide claims

Nov 29, 2018
The giant multinational corporation Bayer is selling off the Dr. Scholl’s and Coppertone brands acquired four years ago when the company bought Merck. Now Bayer is looking to expand its cancer drug research and development and the agribusinesses it’s been…

Here's why Obamacare premiums are going down for the first time

by
Oct 12, 2018
It's "really about returning excess profits," a Kaiser Family Foundation executive says.
John Moore/Getty Images

Kickbacks or a helpful service? Here's why pharma is under fire

Sep 21, 2018
Drug companies can get creative with doctor incentives, and that can be problematic.
A pharmacy technician counts out a prescription of antibiotic pills.
Joe Raedle/Getty Images

Here's why there's a shortage of EpiPens

Aug 23, 2018
The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen…

You’ve got questions. We help you answer them.

Support nonprofit, independent journalism that makes you smarter.

The FDA approves the first drug derived from cannabis

Jun 28, 2018
Will this be the catalyst for big pharmaceutical companies to get into the pot business?
An assistant studies cannabis leaves in the Maripharma Laboratory in Rotterdam, Netherlands, in 2002.
Michel Porro/Getty Images

Exploring the link between housing and health

Jun 13, 2018
Kaiser joins other healthcare organizations investing in affordable housing.
Sidney Bond (left) meets with peer recovery specialist Nathan Thomas at Baltimore's Health Care for the Homeless.
Amy Scott/Marketplace

Capping out-of-pocket drug costs for Medicare patients wouldn't lower drug prices

Apr 30, 2018
Several health economists and policy experts argue until Washington forces drug companies to lower their overall prices, an out-of-pocket Medicare cap is just dabbling at the edges.
A pharmacy technician counts out a prescription of antibiotic pills.
Joe Raedle/Getty Images